Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Biogen stock whipsaws despite FDA granting full approval for Alzheimer
Stock Market

Biogen stock whipsaws despite FDA granting full approval for Alzheimer’s drug; analysts explain why By Investing.com

© Reuters. FDA converts Biogen and Eisai’s Alzheimer’s treatment to traditional approval The U.S. Food and Drug Administration (FDA) converted the approval status of Leqembi

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Stock Market

Cannabis M&A Speculation Whipsaws Hexo Stock on Tilray Takeover Before Reality Set In

Cannabis stocks were in focus on Tuesday afternoon as Tilray Brands Inc (US:TLRY, CA:TLRY) announced its latest M&A transaction with rival Hexo Corp (US:HEXO, CA:HEXO) in its